Wedbush Reaffirms Outperform Rating for Novadaq Technologies Inc. (NDQ)

Wedbush reissued their outperform rating on shares of Novadaq Technologies Inc. (TSE:NDQ) in a research note published on Tuesday. The brokerage currently has a C$17.00 price target on the stock.

Separately, Royal Bank Of Canada reissued an outperform rating on shares of Novadaq Technologies in a report on Thursday, July 7th.

Shares of Novadaq Technologies (TSE:NDQ) opened at 15.94 on Tuesday. The stock has a 50 day moving average of $15.23 and a 200-day moving average of $13.79. Novadaq Technologies has a 52 week low of $10.81 and a 52 week high of $20.40. The stock’s market cap is $915.51 million.

Novadaq Technologies Company Profile

Novadaq Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.